Compiling Pre-DSHEA Ingredient List Relies On Bridging FDA-Industry Gap

"Nobody said these are easy questions, if they were they would have been answered a long time ago," says Steve Tave, director of FDA's Office of Dietary Supplement Programs. Industry stakeholders at a public meeting recommend a reasonable threshold for evidence that verifies a dietary ingredient was available in the US before Congress passed DSHEA.

Bumpy road crossing plains at sunset

More from Regulation

More from Policy & Regulation